BAP1 and neoplasm: Therefore, we hypothesised that somatically altered BAP1 might serve as a critical ingredient contributing to the PD-L1 expression in ccRCC tumor cells, and most likely work in concert with PD-L1 in tumor cells contributing to the aggressiveness of ccRCC.